| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |